Delivery Order SPE2DB25D2203-SPE2DB25FPSJT
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,670.90 by the Defense Logistics Agency for ProQuad vials, with an ultimate completion date of September 23, 2025. The contract employs firm fixed-price pricing and was awarded on a competitive basis without set-aside restrictions. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency on September 11, 2025, for the supply of ProQuad vials. This non-competitive, firm fixed-price delivery order is expected to be completed by October 2, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency (DLA) for ProQuad vials, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of ProQuad vials with a ceiling value of $1,670.90. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $24,814.95 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 24, 2025, with an ultimate completion date of October 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement. The delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,055.26 by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of ProQuad vials. The contract features firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by September 23, 2025, at the vendor's Conshohocken facility. This delivery order operates as...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,543.30 to AmerisourceBergen Drug Corp for ProQuad vials on September 12, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DB25D2203Indefinite Delivery Contract
- SPE2DB25D2203-SPE2DB25FPSJTDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of ProQuad vials with an ultimate completion date of October 17, 2025. The contract is competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain, supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The ProQuad vial delivery supports the Defense Health Agency and other government healthcare systems through the broader global pharmaceutical support vehicle, which encompasses vaccines, medications, and specialized medical commodities across multiple therapeutic domains. The company's demonstrated capability to meet federal procurement requirements through open competition reflects its significant role in supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/25/25 |